Progress On Adding OTC Drugs To US Market? Room To Move But Label Format Limits Options
Executive Summary
Changes for supporting OTC labeling for drugs currently available Rx-only and indicated for chronic, more complicated conditions, aren’t minor and won’t happen within limits of one-dimensional text media printed on OTC drug containers, packages and inserts.
You may also be interested in...
Facilitating More OTC Switches In US Graduates To Regulatory Plan On FDA’s Unified Agenda
For first time rules for novel switches and OTC hearings aids are parts of “significant regulatory actions” in agency’s plans. Information is added in Unified Agenda items explaining likely benefits and costs from the changes.
Innovation, Education Are CHPA Priorities To Help Consumers ‘Own’ Their Health Through Self-Care
“What can we do to help self-care and consumers in their journey? One is innovation, bringing different types of products to market and two, educating consumers because it's complicated. Health care is complicated, and people have a lot of things on their minds,” says CHPA president and CEO Scott Melville.
Room Available In US Pharma Industry For OTC Switch Leader: Has Perrigo Made A Reservation?
Acquiring HRA Pharma, Perrigo could take OTC switch lead, likely starting with HRA’s daily oral contraceptive before moving to numerous other potential candidates. Pharmas previously busy in switch have other priorities for their consumer health businesses.